tranexamic acid

Ukraine

Drugs containing this active substance

  • ACEMIK

    The drug is used for the short-term treatment of bleeding or the risk of its occurrence. It is applied in cases of excessive menstrual bleeding, nosebleeds, after certain surgeries (on the bladder or prostate), during cervical conization, after eye injuries (hyphema), in hereditary angioedema, as well as during tooth extractions in people with hemophilia.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Artura Pharmaceuticals Pvt. Ltd.

  • The drug is used to stop bleeding or prevent the risk of bleeding caused by an increase in the process of blood clot dissolution (fibrinolysis). This applies to both adults and children aged 1 year and older. It is used in gynecological bleeding, gastrointestinal bleeding, dental, and other surgical interventions.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

  • The drug is used to stop bleeding or prevent the risk of bleeding in cases of increased fibrinolysis (the process of dissolving blood clots). It is used for various types of bleeding, including gastrointestinal, gynecological, and dental bleeding, as well as during surgical operations.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 50 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

  • The drug is used to stop bleeding or prevent the risk of bleeding during enhanced fibrinolysis (the process of dissolving blood clots). It is applied in gastrointestinal bleeding, gynecological surgeries, dental interventions, urinary tract surgeries, and other surgical manipulations.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Steril-Jen Life Sciences (P) Ltd

  • The drug is used to stop bleeding or prevent the risk of bleeding during enhanced dissolution of blood clots (fibrinolysis). It is applied in cases of menstrual bleeding, gastrointestinal bleeding, after dental or surgical operations, as well as to control bleeding during the administration of specific medicinal products.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: PT. Novell Pharmaceuticals Laboratories

  • The drug is used to stop bleeding or prevent it if it is associated with an increased process of clot breakdown (fibrinolysis). This applies to both general conditions (e.g., during surgery) and local bleeding (uterine, gastrointestinal, after tooth extraction, or certain surgical interventions).

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 50 mg/ml

    ATC: B02AA02

    Manufacturer: Farmasel LLC (full cycle; control, batch release)

  • The drug is used to stop bleeding or prevent it in cases of increased clot dissolution (fibrinolysis). It is prescribed to adults and children from 1 year of age for gastrointestinal bleeding, gynecological issues (e.g., heavy menstruation), after dental or surgical interventions, as well as for controlling bleeding when using other specific medications.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Immacul Lifesciences Private Limited

  • The drug is used for short-term therapy of bleeding or the risk of its occurrence. It is applied for nosebleeds, excessive menstrual bleeding (menorrhagia), after certain surgeries (on the bladder or prostate), during cervical conization, post-traumatic hyphema, hereditary angioedema, as well as during tooth extraction in patients with hemophilia.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Farmak JSC

  • The drug is used to stop bleeding or to prevent the risk of bleeding during enhanced clot dissolution (fibrinolysis). This applies to both general conditions and local cases, such as during gynecological, dental, or surgical operations, or gastrointestinal bleeding.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: LLC Scientific and Production Company "Mikrokhim" (Responsible for batch release, excluding batch control/testing)

  • The drug is used to stop bleeding or prevent the risk of bleeding during enhanced clot dissolution (fibrinolysis). It is applied in gastrointestinal bleeding, gynecological issues (e.g., heavy menstruation), dental and other surgical interventions, as well as for controlling bleeding after the administration of special clot-dissolving drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: LLC NPF "MIKROKHEM" (responsible for manufacturing and quality control/testing of the batch, excluding batch release; responsible for batch release, excluding quality control/testing of the batch)

  • The drug is used to stop bleeding or prevent the risk of bleeding during increased clot dissolution (fibrinolysis). It is used for menstrual bleeding, gastrointestinal bleeding, after dental or surgical operations, as well as to control bleeding during the administration of special thrombolytic drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 500 mg/5 ml

    ATC: B02AA02

    Manufacturer: Bioindustria Laboratorio Italiano Medicinali S.P.A.

  • It is used to stop bleeding or to prevent the risk of bleeding in cases of enhanced fibrinolysis (the process of dissolving blood clots). This applies to both adults and children aged 1 year and older. Specifically, the drug is used during gynecological operations, dental interventions (tooth extractions), gastrointestinal bleeding, as well as during major surgical operations.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Yuria-Pharm LLC

  • The drug is used for the prevention and treatment of bleeding caused by fibrinolysis. It is prescribed for menstrual bleeding, gastrointestinal bleeding, after surgical interventions (e.g., in dentistry, gynecology, ENT practice, or cardiovascular surgery), and for bleeding control.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Mankind Pharma Limited

  • The drug is used for the prevention and treatment of bleeding caused by fibrinolysis in adults and children aged 1 year and older. It is applied for menstrual bleeding, gastrointestinal bleeding, during dental, gynecological, ENT surgeries, and other major surgical interventions.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Steril-Djen Life Sciences (P) Ltd.

  • The drug is prescribed for adults and children aged 1 year and older for the prevention and treatment of bleeding caused by general or local fibrinolysis. This includes menstrual bleeding, gastrointestinal bleeding, as well as the control of bleeding during surgical interventions (e.g., in dentistry, gynecology, cardiac surgery, etc.).

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Mankind Pharma Limited

  • The drug is used to stop bleeding or prevent it if it is caused by an acceleration of the blood clot dissolution process (fibrinolysis). It is applied in gastrointestinal bleeding, heavy menstruation, after dental or gynecological surgeries, as well as for controlling bleeding during the administration of special medicinal products.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Halychpharm"

  • The drug is used for the prevention and treatment of bleeding caused by general or local fibrinolysis. It is applied in cases of menstrual bleeding, gastrointestinal bleeding, urinary problems, as well as during surgical interventions (ear, nose, throat, gynecology, thoracic, abdominal, and cardiovascular surgery).

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Mankind Pharma Limited

  • The drug is used to stop bleeding or prevent the risk of bleeding during increased clot dissolution (fibrinolysis). It is applied in cases of menstrual bleeding, gastrointestinal bleeding, dental and other surgical operations, as well as for controlling bleeding after the administration of special drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Labiana Pharmaceuticals, S.L.U.

  • The drug is used to stop bleeding or prevent the risk of bleeding during enhanced clot dissolution (fibrinolysis). This applies to both adults and children aged 1 year and older. Specifically, it is used for menstrual bleeding, gastrointestinal bleeding, after dental or surgical procedures, and to control bleeding when using specific medicinal products.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Immacul Lifesciences Private Limited

  • The drug is used to stop or prevent bleeding associated with increased fibrinolysis. This may include uterine, gastrointestinal, or nasal bleeding, postoperative bleeding (e.g., after parotid gland surgery, tonsillectomy, or tooth extraction in patients with hemophilia), or in cases of hereditary angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 250 mg

    ATC: B02AA02

    Manufacturer: Macleods Pharmaceuticals Limited

  • The drug is used to stop bleeding or prevent it in cases of enhanced fibrinolysis. This includes uterine, gastrointestinal, and nasal bleeding, as well as bleeding following certain surgical procedures (e.g., tooth extraction in patients with hemophilia, surgeries on the parotid gland or cervix) and in cases of hereditary angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Macleods Pharmaceuticals Limited

  • The drug is used for the short-term treatment of bleeding or the risk of its occurrence in conditions such as excessively heavy menstruation, nosebleeds, bladder or prostate interventions, cervical conization, traumatic hyphema, as well as in hereditary angioedema and tooth extraction in patients with hemophilia.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: PJSC "Tekhnolog"

  • The drug is used to stop bleeding or prevent the risk of bleeding in cases of increased fibrinolysis. It is prescribed for menstrual bleeding, gastrointestinal bleeding, after dental or surgical operations (e.g., adenoidectomy, heart surgery, gynecological interventions), and to control bleeding when using certain medicinal products.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 50 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Lekhim-Kharkiv"

  • The drug is used to stop bleeding or prevent the risk of bleeding in cases of increased fibrinolysis. It is applied for menstrual bleeding, gastrointestinal bleeding, following dental, gynecological, or surgical operations, and to control bleeding when using other medicinal products.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Lekhim-Kharkiv"

  • The drug is used to stop bleeding or prevent the risk of bleeding during increased fibrinolysis. It is prescribed for gastrointestinal bleeding, gynecological surgeries, dental interventions (tooth extraction), tonsillectomy or adenoidectomy, as well as during major surgical interventions, such as cardiovascular surgery.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 50 mg/ml

    ATC: B02AA02

    Manufacturer: PJSC "Lekhim-Kharkiv"

  • The drug is used for the prevention and treatment of bleeding caused by fibrinolysis. It is applied in cases of menstrual bleeding, gastrointestinal bleeding, post-operative periods (including ENT, gynecological, cardiovascular, and other surgeries), as well as for controlling bleeding when using thrombolytic agents.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used for the prevention and treatment of bleeding caused by fibrinolysis. This applies to adults and children aged 1 year and older, specifically for menstrual bleeding, gastrointestinal bleeding, ENT surgeries, gynecological and surgical interventions on the organs of the thoracic and abdominal cavities, as well as hemorrhagic complications of therapy.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 50 mg/ml

    ATC: B02AA02

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used to stop bleeding or prevent it in various conditions: uterine, gastrointestinal, and nasal bleeding, as well as after certain surgeries (prostate, teeth, cervix, etc.). It is also used for hereditary angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used to stop bleeding or prevent the risk of bleeding in cases of increased fibrinolysis. It is applied for a number of conditions, such as excessive menstruation, gastrointestinal bleeding, hemorrhagic urinary tract disorders, as well as during dental, gynecological, and other major surgical operations.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Yujia Pharma Specialities Limited Unit-III

  • The drug is used to stop or prevent bleeding associated with increased fibrinolysis (for example, in uterine or nasal bleeding, after prostate or cervical surgery, during tooth extraction in patients with hemophilia), as well as in hereditary angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Tulip Lab Pvt. Ltd.

  • The drug is used to stop bleeding or prevent the risk of bleeding during the enhancement of the clot dissolution process. This applies to both general conditions (e.g., during surgery) and local bleeding (uterine, gastrointestinal, after tooth extraction, or certain surgical interventions).

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Steril-Jen Life Sciences (P) Ltd

  • The drug is used for short-term therapy of bleeding or the risk of its occurrence. It is prescribed for nosebleeds, excessive menstrual bleeding (menorrhagia), after certain surgeries (on the bladder or prostate), during cervical conization, post-traumatic hyphema, hereditary angioedema, as well as during tooth extraction in patients with hemophilia.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Kusum Healthcare Pvt Ltd (manufacturing, primary packaging, secondary packaging, quality control, batch release or manufacturing bulk products)